Granules India Limited
NSE:GRANULES.NS
Overview | Financials
Company Name | Granules India Limited |
Symbol | GRANULES.NS |
Currency | INR |
Price | 584.5 |
Market Cap | 141,664,680,500 |
Dividend Yield | 0.38% |
52-week-range | 360.1 - 721 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D. |
Website | https://www.granulesindia.com |
An error occurred while fetching data.
About Granules India Limited
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD